Skip to main content

PERSPECTIVE article

Front. Public Health , 25 May 2022

Sec. Infectious Diseases: Epidemiology and Prevention

Volume 10 - 2022 | https://doi.org/10.3389/fpubh.2022.892290

Importance of the Precautionary Principle With Regard to the Risk of Exposure to Aerosols Containing Viral Loads of SARS-CoV-2 Present in Feces: In Perspective

\nRichard MassicotteRichard Massicotte1Mafu Akier Assanta
Mafu Akier Assanta2*Kakese Mukosa RosetteKakese Mukosa Rosette3
  • 1Laboratory of Innovation and Analysis of Bioperformance, Ecole Polytechnique de Montreal, Montreal, QC, Canada
  • 2Food Research and Development Centre, Agriculture and Agri-Food Canada, Saint-Hyacinthe, QC, Canada
  • 3Groupe de Recherche sur les Maladies Infectieuses du Porc, Département de Pathologie et Microbiologie, Faculté de Médecine Vétérinaire, Centre de Recherche d'Infectiologie Porcine et Avicole, Université de Montréal, Saint-Hyacinthe, QC, Canada

In COVID-19 infection, the emissions of droplets and aerosols produced by the respiratory tract of contaminated subjects may represent a high risk of spreading the SARS-COV-2 virus in the environment. Thus, studies have shown that there is, at least, another source of droplets and aerosols in which viral particles of SARS-COV-2 can be found. It happens after flushing of toilet to dispose of the stools of a patient who has contracted COVID-19. The presence of viral particles of SARS-COV-2 in the stool could be linked to the concentration of angiotensin-converting enzyme 2 (ACE2) found on the surface of intestinal cells. Therefore, there is a reason to wonder whether the emission of viral particles by activating a toilet flush could represent an important potential risk of contamination for health care workers. To investigate this hypothesis, we have correlated different studies on the production of droplets and aerosols as well as the presence of viral particles following flush of toilet. This pooling of these studies led to the following conclusion: the precautionary principle should be applied with regard to the potential risk represented by viral particles of SARV-COV-2 in the stool when flushing the toilet.

Introduction

The SARS-CoV-2 virus, which caused the COVID-19 pandemic, is an enveloped single-stranded RNA virus that is a type of coronavirus. It is 80% genetically similar to SARS-CoV, which caused the severe acute respiratory syndrome (SARS) epidemic in 2002 (1, 2). The main recognized mode of transmission of this type of virus is the diffusion of particles in the form of contaminated droplets from the respiratory system. During the 2002 SARS epidemic, researchers found viral particles of the virus in the stool of infected people such as 2002 SARS,SARS-CoV-2 viral particles found in the stool of infected people (38). The presence of SARS-COV-2 viral particles in the stool has raised the hypothesis of a possible fecal–oral contamination route (5, 9). In addition, the Institut National d'Excellence en Santé et Services Sociaux in Quebec, Canada (10), conducted a review of the literature on COVID-19 and gastrointestinal symptoms. This organization has come to the conclusion that a small proportion of people (on average 7.8%) with COVID-19 may have gastrointestinal symptoms. For their part, Pan et al. (11) found that about 17% of cases with gastrointestinal problems presented with diarrhea or had loose stool. Now, the Centers for Disease Control and Prevention (CDC) also considers diarrhea a symptom of COVID-19 (12). The cause of the diarrhea may be related to the invasion of enterocytes that have angiotensin-converting enzyme 2 (ACE2) on their surface. These proteins promote binding with SARS-CoV-2 (13, 14). The presence of ACE2 would particularly favor the infection of enterocytes by coronaviruses (15). This infection would alter the functions of the intestinal mucosa, thus causing diarrhea.

During the SARS epidemic in 2002, it was found that diarrhea was more frequent during the first 6 days of illness and could last for 21 days after the onset of symptoms (Figure 1) (16). As SARS-CoV-2 is genetically closely related to the 2002 SARS virus (17, 18), it is therefore not surprising that SARS-CoV-2 viral particles can be found in the stool of patients infected with this virus several days after the disappearance of respiratory symptoms (8).

FIGURE 1
www.frontiersin.org

Figure 1. Percentage of SARS patients with diarrhea during the first 21 days of illness (16).

The Issue

The presence of SARS-CoV-2 viral particles in feces raises important questions about the risk that handling stool poses to healthcare workers. First, there is a potential danger of splashing with liquid stool when transporting bedpans to empty them. Second, there is also a potential risk of exposure when the stool is in the toilet. This threat is believed to come from the creation of droplets and aerosols laden with SARS-CoV-2 virus when the toilet is flushed. There is therefore a risk of possible exposure by aerosol for the general population in public toilets (19, 20) as well as the healthcare workers caring for patients with COVID-19 Despite the context of the pandemic, this risk of contamination for health personnel is not generally considered by public health authorities because it is not a proven risk, which would require the implementation of preventive procedures. Although this contamination risk has not yet been proven, the various studies carried out so far tend to show that this path presents a plausible danger of contamination.

Johnson et al. (21) characterized, by size, the emissions spread by three different types of toilets when flushed. They observed that the emissions in the form of droplets, meaning having a diameter of 5 μm and more, constitute the smallest quantity of particles emitted, regardless of the model of toilet, compared to aerosols (smaller than 5 μm). Because of their size, the droplets fall quickly on neighboring surfaces, including sinks, faucets and toilet paper dispensers. These droplets thus present a risk of contamination by indirect contact (22, 23). Depending on the environmental conditions, if the surfaces are not adequately cleaned and disinfected, there is the possibility of to have an airborne resuspension of the virus.

According to the results of Johnson et al. (21), all of the emissions produced when a toilet is flushed end up in the form of an aerosol. This observation is corroborated by Knowlton (24). In light of these observations, potentially contaminated aerosols that came from a toilet may remain suspended in the air for a longer time and therefore may travel longer distances, depending on environmental conditions. It is important to emphasize that the environmental conditions can not only favor the agglomeration of the particles but also allow them to contract and dry out (25), thus making it possible for them to remain suspended in the air for longer. Eventually, they will settle on a surface and, if the virus is still viable, the surface may become a potential vehicle for indirect transmission some distance from the emission source (23, 26, 27).

Using the MS2 phage, Cooper (28) studied the presence of viral particles in an aerosol generated by a flushing toilet in a bathroom. The results of the study showed that the concentration of the phage in the air was high 4 min after the toilet was flushed (Figure 2). After 1 h, the viral load was reduced ~20-fold. It is important to note that the results of Cooper (28) were obtained using a single toilet flush in an environment where there were about 10 air exchanges per hour.

FIGURE 2
www.frontiersin.org

Figure 2. Average concentration of MS2 phases per m3 as a function of time after one flush (28).

It is interesting to make a connection between the studies of Gerba et al. (22), Cooper (28), and Barker and Jones (29). Gerba et al. (22) and Barker and Jones (29) demonstrated that a significant amount of virus remained on toilet surfaces after a single flush. Some of this viral load that has remained in the toilet can be suspended by a few toilet flushes afterwards, as shown in Figure 3. As demonstrated by Cooper (28), an emission of viral particles is found suspended in the air for some time in the form of droplets and aerosols after the toilet has been flushed. Hypothetically, if there is a virus in the toilet, the frequency of toilet flushing could play a role in maintaining a certain SARS-CoV-2 viral load in the air for a longer period of time. By correlation, this would thus promote an increase or to keep of the concentration of the virus in the air, in addition to increasing the risk of contamination of the various surfaces present, all depending on the environmental conditions.

FIGURE 3
www.frontiersin.org

Figure 3. Effect of flushing on removal of exogenously added bacteria and viruses to the toilet bowl (22).

Discussion

During this pandemic period, the issue of aerosols is particularly worrying, because viable viral particles of SARS-CoV-2 have been found in stool (8) and toilets are sources of droplet and aerosol emissions laden with viral fecal particles (24, 28). These particles emitted when the toilet is flushed could contribute to the environmental viral load of SARS-CoV-2. Some of this load is found in the air for a while in particles, for which the size modulates the distribution of the virus throughout the respiratory tract (30) when they are inhaled. This means that if viable particles of the virus contained in aerosols end up in the lungs, they would be a potential source for the onset of COVID-19 symptoms. There is an abundance of ACE2 proteins in the lungs (2020). It should be noted that this virus may have a low infectious dose (31) and it can survive for hours in aerosols and on surfaces it is deposited on, depending on environmental conditions and the type of surface (32).

Still, the presence of viable particles of this type of virus appears to be in frequent in the stool, and the survival rate is unknown due to environmental stress when the particles are released into the environment (33). The virulence of the pathogen, the environmental load present, the ability of the pathogen to spread, and the vulnerability of the host mean that SARS-CoV-2, in the form of droplets and aerosols from toilets, presents a potential infectious risk that should be considered in health care settings. Due to the level of uncertainty surrounding this risk, it is currently not considered to be a proven, known risk. In this context, it is difficult to apply prevention principles that seek to reduce the risks associated with an established and recognized danger.

The failure to apply the precautionary principle today is of particular concern because in 1985 (34) demonstrated for the first time that a coronavirus present in an aerosol can survive at least 3 days in the air according to the environmental conditions.

This concern applies, among other things, when flushing a toilet containing contaminated stool, emissions of droplets and aerosol contaminated with SARS-COV-2 are produced. As we found with the work of Gerba et al. (22), the toilet must be flushed at least three times to adequately reduce the risk of contaminated emissions. Knowing that each time we operate the toilet there is formation of aerosol which remains in suspension for a certain time. Therefore, environmental microbial and viral load increase according to the frequency of action of the toilet and of the traffic of these.

These emissions could therefore represent a potential infectious risk for people in the environment of the emitting source. Admittedly, the entire population is exposed to this risk, but for healthcare personnel, the presence of potentially contaminated emissions from toilets can add to the environmental load from the respiratory tract of patients with COVID-19 (35, 36). According to Birgand et al. (37), the degree of air contamination by SARSCoV-2 in hospitals reported to be positive for 24% of air samples from toilets with an average of viral RNA concentrations per m3 air higher than that of any other area sampled. This increase in the environmental load also represents an increase in the risk of contamination for personnel.

However, if it is desired to reduce a hypothetical but plausible potential risk, a proactive approach can be adopted by applying the precautionary principle. Because of the evolution of the COVID-19 pandemic and the lack of knowledge, it would be logical and rational to implement preventive precautions to reduce the risks of exposure of healthcare personnel to SARS-CoV-2.

Conclusion

The originality of this article comes from the fact that it combines the results of different works relating to the characterization of the emissions produced when we flush the toilet, the number of times we have to flush the toilet to significantly reduce the risk of infection as well as the variation in the concentration of the virus in the air as a function of time. Combination of these information linked to the results of work carried out more recently by various researchers (19, 20, 37, 38) which demonstrated the presence of SARS-COV-2 in emissions from toilets clearly indicates that the risk of exposure to aerosols contaminated by SARS-COV-2 can persist for some time, even in the absence of contaminated stools in the toilet.

Hypothetically, with regard to ventilation, the dispersion of SARS-COV-2 in aerosol form could exceed the limits of the bathroom. Therefore, particular attention should be paid to this source of potential contamination and especially in a hospital environment by applying the precautionary principle, i.e., applying stricter protective measures.

However, studies have not yet demonstrated a direct cause and effect link between the aerosols produced when we activate a toilet flush and cases of contamination of people (39). This lack of proven evidence does not encourage public health authorities to recommend stricter protective measures for healthcare workers. Hence extensive research in line with this finding should be carried out in the future. However, in view of current knowledge to limit the risks of contamination in the absence of infection prevention protocols precautionary principle is an important avenue to proactively consider. Compliance with this principle will help reduce exposure to the potential infectious risk of SARS-CoV-2 in aerosol form in the healthcare environment.

Data Availability Statement

The figures presented in this study are based on those find in the corresponding references. The further inquiries can be directed to the corresponding author.

Author Contributions

RM contributed to the conception of the work. MA contributed to revised the paper. KR contributed to the supervision of the manuscript. All authors contributed to the article and approved the submitted version.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Acknowledgments

The authors would like to thank the Research and Development Center of Agriculture and Agri-Food Canada (FRDC-AAFC) for their financial support, which made this publication possible.

References

1. Cheng PK, Wong DA, Tong LK, Ip SM, Lo AC, and Lau CS. Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet. (2004) 363:1699–700. doi: 10.1016/S0140-6736(04)16255-7

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Xu D, Zhang Z, Jin L, Chu F, Mao Y, Wang H. Pe rsistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase. Eur J Clin Microbiol Infect Dis. (2005) 24:165–71. doi: 10.1007/s10096-005-1299-5

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Chen W, Lan Y, Yuan X, Deng X, Li Y, Cai X. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg Microbes Infect. (2020) 9:469–73. doi: 10.1080/22221751.2020.1732837

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Tang A, Tong ZD, Wang HL, Dai YX, Li KF, Liu JN. Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child, China. Emerg Infect Dis. (2020) 26:301. doi: 10.3201/eid2606.200301

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. (2020) 158:1831–3.e3. doi: 10.1053/j.gastro.2020.02.055

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Amirian E. Review Potential fecal transmission of SARS-CoV-2: Current evidence and implications for public health review. Int J Infect Dis. (2020) 95:363–70. doi: 10.1016/j.ijid.2020.04.057

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Parasa S, Desai M, Chandrasekar VT, Patel HK, Kennedy KF, Roesch T, et al. Gastroenterology and hepatology prevalence of gastrointestinal symptoms and fecal viral shedding in patients with coronavirus disease 2019. A systematic review and meta-analysis. JAMA Network Open. (2020) 3:14. doi: 10.1001/jamanetworkopen.2020.11335

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Wang X, Zheng J, Guo L, Yao H, Wang L, Xia XD. Fecal viral shedding in COVID-19 patients: clinical significance, viral load dynamics and survival analysis. Virus Res. (2020) 289:198147. doi: 10.1016/j.virusres.2020.198147

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Chen Y, Chen L, Deng Q, Zhang G, Wu K, Ni L. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. J Med Virol. (2020) 92:833–40. doi: 10.1002/jmv.25825

PubMed Abstract | CrossRef Full Text | Google Scholar

10. L'Institut national d'excellence en santé et services sociaux du Québec (INESSS). COVID-19 et symptômesgastrointestinaux. Québec: L'Institut national d'excellence en santé et services sociaux du Québec (2020). p. 12.

Google Scholar

11. Pan Y, Zhang D, Yang P, Poon LLM, Wang Q. Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis. (2020) 20:411–2. doi: 10.1016/S1473-3099(20)30113-4

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Centers diseases Control Prevention (CDC). Symptoms of COVID-19. (2021). Available online at: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html

Google Scholar

13. Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. (2004) 203:631–7. doi: 10.1002/path.1570

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Chen Y, Guo Y, Pan Y, Zhao ZJ. Structure analysis of the receptor binding of 2019- nCoV. Biochem Biophys Res. (2020) 525:135–40. doi: 10.1016/j.bbrc.2020.02.071

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Zhanga H, Lib H-B, Lyuc J-R, Leic X-M, Lic W, Lyud J, et al. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection. Int J Infect Dis. (2020) 96:19–24. doi: 10.1016/j.ijid.2020.04.027

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Leung WK, To KF, Chan PKS, Chan HLY, Wu AKL, Lee N. Enteric involvement of severe acute respiratory syndrome–associated coronavirus infection. Gastroenterology. (2003) 125:1011–7. doi: 10.1016/S0016-5085(03)01215-0

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS. Coronavirus disease 2019–COVID-19. Clin Microbiol Rev. (2020) 33:e00028. doi: 10.1128/CMR.00028-20

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Lu R, Zhao X, Li J. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. (2020) 395:565–74. doi: 10.1016/S0140-6736(20)30251-8

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Dancer SJ, Li Y, Hart Y, Tang JW, Jones DL. What is the risk of acquiring SARS-CoV-2 from the use of public toilets? Sci Total Environ. (2021) 792:148341. doi: 10.1016/j.scitotenv.2021.148341

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Schreck JH, Lashaki MJ, Hashemi J, Dhanak M, Verma S. Aerosol generation in public restrooms. Phys Fluids. (2021) 33:12. doi: 10.1063/5.0040310

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Johnson DL, Mead KR, Lynch RA, Hirst DVL. Lifting the lid on toilet plumeaerosol: a literature review with suggestions for future research. Am J Infect Control. (2013) 41:254–8. doi: 10.1016/j.ajic.2012.04.330

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Gerba CP, Wallis C, Melnick JL. Microbiological hazards of household toilets: droplet production and the fate of residual organisms. Appl Microbiol. (1975) 30:229–37. doi: 10.1128/am.30.2.229-237.1975

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Ong SW, Tan YK, Chia PY, Lee TH, Ng OT, Wong MS. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. (2020) 323:1610–12. doi: 10.1001/jama.2020.3227

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Knowlton SD, Boles CL, Perencevich EN, Diekema DJ, Nonnenmann MW. Bioaerosol concentrations generated from toilet flushing in a hospital-based patient care setting. Antimicrob Resist Infect Control. (2018) 7:16. doi: 10.1186/s13756-018-0301-9

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Verreault D, Moineau S, Duchaine C. Methods for Sampling of Airborne Viruses. (2008). Available online at: https://pubmed.ncbi.nlm.nih.gov/18772283/

Google Scholar

26. Caul EO. Small round structured viruses - airborne transmission and hospital control. Lancet. (1994) 343:1240–2. doi: 10.1016/S0140-6736(94)92146-6

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Santarpia J, Rivera D, Herrera V, Morwitzer MJ, Creager H, Santarpia GW, et al. Transmission potential of SARS-CoV-2 in viral shedding observed at the University of Nebraska Medical Center. medRxiv Preprint Server. (2020). doi: 10.1101/2020.03.23.20039446

CrossRef Full Text | Google Scholar

28. Cooper J. The role of hospital toilets in microbial dissemination and the effectiveness of ultraviolet C irradiation. The University of British Columbia, Thesis, University of British Columbia (Vancouver) (2017). p. 91.

Google Scholar

29. Barker J, Jones MV. The potential spread of infection caused by aerosolcontamination of surfaces after flushing a domestic toilet. J Appl Microbiol. (2005) 99:339–47. doi: 10.1111/j.1365-2672.2005.02610.x

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Schlesinger RB. Comparative deposition of inhaled aerosols in experimental animals and humans: a review. J Toxicol Environ Health. (1985) 15:197. doi: 10.1080/15287398509530647

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Lee PI, Hsueh PR. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. J MicrobiolImmunol Infect. (2020) 53:365–7. doi: 10.1016/j.jmii.2020.02.001

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Van Doremalen J, Bushmaker T, Morris HD, Holbrook MG, Gamble A, Williamson BN. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1, Letters. N Engl J Med. (2020) 382:16. doi: 10.1056/NEJMc2004973

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Roy CJ, Milton DK. Airborne transmission of communicable infection-the elusive pathway. N Engl J Med. (2004) 350:1710–2. doi: 10.1056/NEJMp048051

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Ijaz MK Brunner AH Sattar SA Nair RC and Johnson-Lussenburg CM. Survival characteristics of airborne human coronavirus 229E. J Gen Virol. (1985) 10:2743–8. doi: 10.1099/0022-1317-66-12-2743

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Lednicky JA, Lauzardo M, Fan ZH, Jutla A, Tilly TB, Gangwar M. ViableSARS-CoV-2 in the air of a hospital room with COVID-19 patients. Int J Infect Dis. (2020) 100:476–82. doi: 10.1016/j.ijid.2020.09.025

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Ma J, Qi X, Chen H, Li X, Zhang Z, Wang H, et al. COVID-19 patients in earlierstages exhaled millions of SARS-CoV-2 per hour. Clin Infect Dis. (2020) 28:ciaa1283. doi: 10.1093/cid/ciaa1283

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Birgand G, Peiffer-Smadja N, Fournier S, Kerneis S, Lescure FX, Lucet JC. Assessment of air contamination by SARS-CoV-2 in hospital settings. Open. (2020) 1:e2033232. doi: 10.1001/jamanetworkopen.2020.33232

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Yu ITS, Li Y, Wong TZ, Tam W, Chan AT, Lee JHW, et al. Evidence of airborne transmission. N Engl J Med. (2004) 350:1731–9. doi: 10.1056/NEJMoa032867

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Vardoulakis S, Sheel M, Lal A, Gray D. COVID-19 environmental transmissionand preventive public health measures. Aust N Z J Public Health. (2020) 44:333–5. doi: 10.1111/1753-6405.13033

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: COVID-19, aerosol, toilet, emission, exposure

Citation: Massicotte R, Assanta MA and Rosette KM (2022) Importance of the Precautionary Principle With Regard to the Risk of Exposure to Aerosols Containing Viral Loads of SARS-CoV-2 Present in Feces: In Perspective. Front. Public Health 10:892290. doi: 10.3389/fpubh.2022.892290

Received: 08 March 2022; Accepted: 20 April 2022;
Published: 25 May 2022.

Edited by:

Luigi Angelo Vaira, Azienda Ospedaliero Universitaria Sassari, Italy

Reviewed by:

Hunter Quon, University of California, Irvine, United States
Marco Verani, University of Pisa, Italy

Copyright © 2022 Massicotte, Assanta and Rosette. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Mafu Akier Assanta, YWtpZXJhc3NhbnRhLm1hZnVAYWdyLmdjLmNh

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

Man ultramarathon runner in the mountains he trains at sunset

95% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more